February 16, 2020: COSMED acquires Innovision ApS Technology to expand presence in the Nordic market

Posted on 16 Februar 2020, English, Company, Italiano, Deutsch, French

February 16, 2020: COSMED acquires Innovision ApS Technology to expand presence in the Nordic market

COSMED Announces Acquisition of Innovision Technology to Expand Product Portfolio and Presence in the Nordic Markets.

COSMED headquartered in Rome, Italy, leading manufacturer of Metabolic and Body composition technologies, has acquired assets of Innovision ApS, a Danish Company with significant know-how and expertise in the design of products for Hemodynamic (Cardiac Output), Ventilation Heterogeneity (Lung Clearance Index) and Metabolic measurements (VO2Max).

February 13, 2020: COSMED announces U.S. FDA 510(K) clearance of Q-NRG+ and Q-NRG Indirect Calorimetry device.

Posted on 14 Februar 2020, English, Company, Italiano, Deutsch, French

February 13, 2020: COSMED announces U.S. FDA 510(K) clearance of Q-NRG+ and Q-NRG Indirect Calorimetry device.

COSMED is glad to announce the U.S. Food and Drug Administration (FDA) clearance of Q-NRG+ and Q-NRG, a metabolic monitoring device utilizing Indirect Calorimetry (IC) technology intended for the measurement of Resting Energy Expenditure (REE) in patients who are mechanically ventilated or spontaneously breathing.

Feb 10, 2020: COSMED commitment during the current COVID-19 global pandemic

Posted on 10 Februar 2020, English, Company, Italiano, Deutsch, French

Feb 10, 2020: COSMED commitment during the current COVID-19 global pandemic

During these exceptional times, we would like to inform you that COSMED is adapting to the COVID-19 situation with diligence and is trying to face this big challenge with determination.

We wanted to take a moment to share with our customers, partners and communities how COSMED is responding to this evolving situation.

August 15, 2019: COSMED and Baxter Announce Partnership to Bring Next-generation Indirect Calorimetry Device, Q-NRG+, to Support Clinical Nutrition Globally

Posted on 15 August 2019, English, Company, Italiano, Deutsch, French

August 15, 2019: COSMED and Baxter Announce Partnership to Bring Next-generation Indirect Calorimetry Device, Q-NRG+, to Support Clinical Nutrition Globally

COSMED Srl, a worldwide leader in the design of metabolic systems for clinical and human performance applications and Baxter International Inc. (NYSE: BAX), a global leader in clinical nutrition, today announced an agreement to commercialize Q-NRG+, a metabolic monitoring device utilizing indirect calorimetry technology.

Cardiopulmonary Exercise Testing. What Is its Value?

Posted on 25 Juni 2018, English, COSMED News, Clinical CPET, Scientific

indirect calorimetry

The role and the value of cardiopulmonary exercise testing (CPET) in cardiology has been examined in this review study on the Journal of the American College of Cardiology.

<<  1 2 3 [45 6 7 8  >>